CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression Free Survival on BTK Inhibitor Therapy

Journal article

Peer reviewed

Anfal Alsadhan, Jonathan Chen, Clare Sun, Chingiz Underbayev, Elena Bibikova, Tanja Nicole Hartmann, Maissa Mhibik and Adrian Wiestner

Blood, Vol.140(Supplement 1), pp.6004-6005

15/11/2022

Metrics

1 Record Views

Title: CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression Free Survival on BTK Inhibitor Therapy
Creators - without role: Anfal Alsadhan - Catholic University of America
Jonathan Chen - National Heart Lung and Blood Institute
Clare Sun - National Heart Lung and Blood Institute
Chingiz Underbayev - National Heart Lung and Blood Institute
Elena Bibikova - 4AstraZeneca, South San Francisco, CA
Tanja Nicole Hartmann - University of Freiburg
Maissa Mhibik - National Heart Lung and Blood Institute
Adrian Wiestner - National Heart Lung and Blood Institute
Publication Details: Blood, Vol.140(Supplement 1), pp.6004-6005
Publisher: Elsevier Inc
Identifiers: 9920883308331
Academic Unit: King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article